Tokyo, May 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061551) titled 'Elucidating the Association Between First-Line Antimalarial Drug Susceptibility and Patient Outcomes in African Severe Malaria: A Prospective Cohort Study Towards Improving Survival Rates' on May 15.
Study Type:
Observational
Primary Sponsor:
Institute - Juntendo University
Condition:
Condition - Malaria
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - Although malaria-related deaths initially declined following the introduction of the highly effective antimalarial drug artemisinin, the trend reversed in 2020 and has since plateaued, resulting in approximately 600,...